Harm minimisation was adopted by Australia during the HIV/AIDS crisis which began in the 1980’s. It was not until 1998, however, that the Federal Government recognised Harm Minimisation as its national drug policy and this approach is recognised internationally as best practice to this day.
Harm Minimisation remains Australia’s federal drug strategy and has kept HIV infections among people who inject drugs to between 1-2%. Harm Minimisation comprises of 3 pillars, Supply Reduction, Demand Reduction and Harm Reduction.
Involves reduction of the supply of drugs in Australia as well as reducing supply coming into Australia across our borders. Supply reduction is conducted primarily by law enforcement and customs agencies. It accounts for the vast majority of harm minimisation funding that the government spends.
Demand Reduction aims to prevent the uptake & delay of first use of drugs in society. It aims to reduce harmful use of drugs through programs such as Opioid Maintenance Treatment (OMT) as well as initiatives that support people to recover from drug use when it has become problematic or harmful for them.
refers to a range of public health policies designed to reduce the harmful consequences associated with high-risk activities such as drug use. Harm Reduction is a central part of the philosophy behind CAHMA. Put simply, Harm Reduction is about reducing, or where possible, removing the harms which may occur when someone is performing some activity. In this case, the activity is using illicit drugs.
Examples of harm reduction in other areas are the introduction of seat belt laws and making seat belts available in all cars (to reduce the harms which drivers were suffering) and the provision of condom vending machines in pub toilets (to reduce unwanted pregnancy and sexually transmitted infections). Further examples include Chill out rooms, Designated Drivers and Legalised Brothels to name just a few. More recently during the Covid-19 pandemic preventative vaccinations have played a major harm reduction role in reducing morbidity from the SARS COV-19 virus.